These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Prevalence of late potentials after myocardial infarction treated with systemic thrombolysis or primary percutaneous transluminal coronary angioplasty. Bruna C, Rossetti G, Vado A, Racca E, Steffenino G, Dellavalle A, Ribichini F, Ferrero V, Menardi E, Uslenghi E. G Ital Cardiol; 1998 Jan; 28(1):3-11. PubMed ID: 9493040 [Abstract] [Full Text] [Related]
6. Primary percutaneous transluminal coronary angioplasty accelerates early myocardial reperfusion compared to thrombolytic therapy in patients with acute myocardial infarction. Zeymer U, Schröder R, Machnig T, Neuhaus KL. Am Heart J; 2003 Oct; 146(4):686-91. PubMed ID: 14564324 [Abstract] [Full Text] [Related]
7. Left ventricular systolic function in myocardial infarction survivors treated with primary angioplasty, thrombolysis of angioplasty preceded by thrombolysis. Gaszewska-Zurek E, Paradowska M, Maślankiewicz K, Gruszka A, Tendera M. Kardiol Pol; 2003 Jul; 59(7):27-37; discussion 37. PubMed ID: 14560346 [Abstract] [Full Text] [Related]
8. A randomized trial of transfer for primary angioplasty versus on-site thrombolysis in patients with high-risk myocardial infarction: the Air Primary Angioplasty in Myocardial Infarction study. Grines CL, Westerhausen DR, Grines LL, Hanlon JT, Logemann TL, Niemela M, Weaver WD, Graham M, Boura J, O'Neill WW, Balestrini C, Air PAMI Study Group. J Am Coll Cardiol; 2002 Jun 05; 39(11):1713-9. PubMed ID: 12039480 [Abstract] [Full Text] [Related]
9. [Usefulness of combination therapy of hybrid thrombolysis followed by back-up percutaneous transluminal coronary angioplasty in patients with acute myocardial infarction]. Mukawa H, Sone T, Tsuboi H, Kondo J, Kosokabe T, Uesugi M, Imai H. J Cardiol; 2001 Apr 05; 37(4):181-9. PubMed ID: 11337927 [Abstract] [Full Text] [Related]
13. Outcome of different reperfusion strategies in patients with former contraindications to thrombolytic therapy: a comparison of primary angioplasty and tissue plasminogen activator. Primary Angioplasty in Myocardial Infarction (PAMI) Investigators. Stone GW, Grines CL, Browne KF, Marco J, Rothbaum D, O'Keefe JH, Hartzler GO, Overlie P, Donohue B, Chelliah N, Vlietstra R, Puchrowicz-Ochocki S, O'Neill WW. Cathet Cardiovasc Diagn; 1996 Dec 05; 39(4):333-9. PubMed ID: 8958418 [Abstract] [Full Text] [Related]